EDIT Q1 2022 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M+4.2% YoY

Gross Profit

-$31M-460.9% margin

Operating Income

-$51M-749.5% margin

Net Income

-$51M-746.0% margin

EPS (Diluted)

$-0.73

QoQ Revenue Growth

-45.7%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$51M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$623M

Total Liabilities

$110M

Stockholders' Equity

$513M

Cash & Equivalents

$211M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$6M	+4.2%
Gross Profit	-$31M	-$35M	+11.9%
Operating Income	-$51M	-$57M	+10.8%
Net Income	-$51M	-$57M	+11.0%